IP Library Patent Application 19019556
Patent Application
App. No. 19/019,556

METHOD OF ESCALATING SOTALOL HYDROCHLORIDE DOSING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/019,556
Abstract

The present invention provides novel methods of initiating and escalating sotalol hydrochloride in patients in need thereof.

Claims (21)

1 . A method of escalating sotalol hydrochloride, dosing comprising:

a. escalating an existing sotalol concentration of a subject to a higher level by administering an intravenous (IV) dose of 105 mg sotalol hydrochloride over a period of 1 hour to the subject, wherein the subject had symptomatic atrial fibrillation or atrial flutter and is currently in sinus rhythm; and

b. after completion of the IV dose, administering oral dosing of one or more oral dose of sotalol hydrochloride to the subject in an amount of 160 mg;

wherein the subject is discharged from the hospital 24 hours after IV initiation.

2 . The method of claim 1 , wherein the oral dosing is initiated 4-12 hours after completion of the IV dose.

3 . (canceled)

4 . The method of claim 1 , wherein the oral dosing is initiated 4-6 hours after completion of the IV dose.

5 . The method of claim 1 , wherein the oral dosing is initiated 6-12 hours after completion of the IV dose.

6 . The method of claim 2 , wherein one or more of the oral doses are administered at an interval of 12-48 hours from initiation of the oral dosing.

7 . The method of claim 4 , wherein one or more of the oral doses are administered at an interval of 12-24 hours from initiation of the oral dosing.

8 . The method of claim 5 , wherein one or more of the oral doses are administered at an interval of 24-48 hours from initiation of the oral dosing.

9 . The method of claim 1 , wherein:

the oral dosing is initiated 4 hours after completion of the IV dose; and

one or more of the oral doses are administered at an interval of 12 hours from initiation of the oral dosing.

10 . The method of claim 1 , wherein:

the oral dosing is initiated 6 hours after completion of the IV dose; and

one or more of the oral doses are administered at an interval of 24 hours from initiation of the oral dosing.

11 . The method of claim 1 , wherein:

the oral dosing is initiated 12 hours after completion of the IV dose; and

one or more of the oral doses are administered at an interval of 48 hours from initiation of the oral dosing.

12 . The method of claim 1 , wherein the subject is receiving 120 mg oral sotalol hydrochloride therapy and the IV dose is administered to escalate the existing sotalol concentration of the subject to a higher concentration before administering the 160 mg oral dose of sotalol hydrochloride.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2025
From: SOMBERG, JOHN CHARIN; KASHFIAN, BRANDON IRA; MOLNAR, JANOS
To: ALTATHERA PHARMACEUTICALS LLC
Reel/Frame 071498/0744 →